ARTBIO
Cambridge
About ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $245.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
- Website: artbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/artbio-57798 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.